Marshall Wace’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.6M Sell
1,600,168
-60,567
-4% -$2.24M 0.06% 294
2025
Q4
$59M Buy
1,660,735
+1,018,256
+158% +$28.6M 0.05% 307
2025
Q3
$9.23M Buy
+642,479
New +$7.61M 0.01% 942
2024
Q4
Sell
-73,905
Closed -$798K 2628
2024
Q3
$798K Buy
+73,905
New +$720K ﹤0.01% 1741
2024
Q1
Sell
-49,466
Closed -$291K 2487
2023
Q4
$291K Sell
49,466
-2,137,832
-98% -$16.4M ﹤0.01% 1898
2023
Q3
$21.3M Buy
2,187,298
+33,211
+2% +$394K 0.04% 415
2023
Q2
$25.5M Buy
2,154,087
+344,708
+19% +$3.95M 0.05% 395
2023
Q1
$19.5M Buy
1,809,379
+328,721
+22% +$4.2M 0.04% 476
2022
Q4
$17.1M Buy
+1,480,658
New +$18.3M 0.04% 519
2022
Q3
Sell
-1,625,817
Closed -$14.7M 3396
2022
Q2
$14.7M Buy
1,625,817
+833,833
+105% +$5.69M 0.03% 632
2022
Q1
$5.93M Sell
791,984
-210,266
-21% -$1.46M 0.01% 1237
2021
Q4
$8.6M Buy
+1,002,250
New +$8.71M 0.02% 969
2019
Q1
Sell
-7,869
Closed -$138K 1759
2018
Q4
$138K Buy
+7,869
New +$233K ﹤0.01% 1324

Other funds holding COGT